Advances of Particle Therapy in Prostate Cancer—2nd Edition

Dear Colleagues,

This Special Issue is the second edition of the previous Special Issue entitled “Advances of Particle Therapy in Prostate Cancer” (https://www.mdpi.com/journal/cancers/special_issues/ZRCA1V3LQ7).

Prostate cancer is the most prevalent cancer among men in the United States. Radiation therapy is one of the major treatment options for prostate cancer. Recent technical advances in external beam RT using photons—for example, SBRT and IMRT—have permitted the delivery of a higher dose to tumors and a lower dose to surrounding tissues. At the same time, basic and clinical research into external RT using particles (particle RT) has been carried out for the purpose of establishing more effective and non-invasive treatments. Among the particles used in such treatments, protons and carbon ions are most commonly used. New technologies and clinical approaches have been developed to improve therapies. This Special Issue aims to introduce recent advances and breakthroughs in the particle treatment of prostate cancer. Submissions of communications, full papers, mini-reviews, and reviews are all welcome. We look forward to your contributions and fruitful discussions.

Dr. Xinning Wang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.